Literature DB >> 30734350

Clinical and economic burden of regularly transfused adult patients with β-thalassemia in the United States: A retrospective cohort study using payer claims.

Mia Weiss1,2, Monika Parisi Jun2, Sujit Sheth3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30734350     DOI： 10.1002/ajh.25429

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.

Authors:  Chao-Hsiun Tang; Wesley Furnback; Bruce C M Wang; Jackson Tang; Derek Tang; Meng-Yao Lu; Vicky W-H Huang; Khaled M Musallam
Journal:  Transfusion       Date:  2021-09-10       Impact factor: 3.337

2.  Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.

Authors:  Shaikha Alshamsi; Samer Hamidi; Hacer Ozgen Narci
Journal:  BMC Health Serv Res       Date:  2022-03-05       Impact factor: 2.655

3.  Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Authors:  Anuraag R Kansal; Odette S Reifsnider; Sarah B Brand; Neil Hawkins; Anna Coughlan; Shujun Li; Lael Cragin; Clark Paramore; Andrew C Dietz; J Jaime Caro
Journal:  J Mark Access Health Policy       Date:  2021-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.